Autoimmune Risks That Affect Pregnancy Outcomes

Credibility

Interest

Key Takeaway

Some inherited risks for certain autoimmune diseases (like Hashimoto’s, type 1 diabetes, and rheumatoid arthritis) can raise the chance of pregnancy problems such as preterm birth and high blood pressure in pregnancy.

What They Found

Researchers used genetic data to see if a person’s inherited risk for autoimmune diseases causes pregnancy problems. They found that higher inherited risk for Hashimoto’s thyroiditis was linked to more early births and more pregnancy high blood pressure, but fewer very large babies. Having higher inherited risk for type 1 diabetes or lupus was linked only to a higher chance of early birth. Higher inherited risk for rheumatoid arthritis raised the chance of pregnancy high blood pressure, while higher risk for ankylosing spondylitis seemed to lower that risk. For other conditions studied (like multiple sclerosis, celiac disease, psoriasis, and others) they did not find clear evidence of an effect on pregnancy outcomes.

Who Should Care and Why

Pregnant people or those planning pregnancy who have autoimmune diseases or a family history of them should care because the study suggests some conditions can change the chances of early birth or high blood pressure in pregnancy. Caregivers and family members can use this information to support earlier monitoring and discussions with doctors about risks—like checking blood pressure and baby growth more often. Healthcare providers may consider these genetic links when deciding how closely to follow someone during pregnancy, similar to stepping up care if a person has diabetes. Patients with Hashimoto’s, type 1 diabetes, rheumatoid arthritis, or lupus may benefit most from extra attention in pregnancy planning and monitoring. This doesn’t mean these outcomes will definitely happen, but it points to who might need closer watchfulness, like checking for signs of early labor or pregnancy high blood pressure sooner.

Important Considerations

This study looked at genetic liability (inherited risk), not current symptoms or the effect of treatments, so results don’t say how controlling disease or medication changes risk. Genetic studies can’t prove every individual will have the same outcome—these are average effects across many people and may not apply to everyone. Also, the study couldn’t fully explain how the immune system causes these effects, so more research is needed before changing treatment plans based only on this information.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Genetics Early Research MS Progression

Article Topics:

Autoimmune conditionsCausalityGeneticMendelian randomizationPregnancy

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like BMC medicine often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News